Spontaneous immune rejection of intraocular tumors in mice. 1985

J Y Niederkorn, and P C Meunier

The growth and spontaneous resolution of syngeneic intraocular tumors were studied in DBA/2 mice. The P91 mutant clone of P815 mastocytoma (DBA/2 origin) expresses potent tumor-specific transplantation antigens (TSTA) that elicit vigorous immune responses in the syngeneic host. P91 tumors grew transiently and underwent spontaneous resolution following intracameral transplantation in DBA/2 hosts. The spontaneous rejection of the intraocular P91 tumors was a T-cell-dependent, radiosensitive immune process since these tumors grew progressively in T-cell-deficient nude mice and sublethally x-irradiated DBA/2 hosts. Intraocular P91 tumors induced vigorous cytotoxic T-lymphocyte (CTL), antibody, and delayed-type hypersensitivity (DTH) responses in immunocompetent DBA/2 hosts. The acquisition of DTH and CTL reactivity against the TSTA on the intraocular P91 tumors coincided with the onset of spontaneous rejection and suggested a pivotal role for cellular immune mechanisms in the destruction of the primary intraocular neoplasms. Moreover, histopathologic features attending tumor regression were compatible with the DTH reaction in the mouse. Tumor regression was associated with extensive vascular margination and emigration of neutrophils among viable tumor cells at the interface of the tumor mass and uveal components. Areas of previous tumor growth were replaced by a bed of granulation tissue accompanied by a mixed inflammatory infiltrate. Although immunocompetent hosts were able to rid their eyes of tumor, all of the eyes eventually became phthisical. The present findings are consistent with the hypothesis that cellular immune processes play a major role in the spontaneous rejection of intraocular tumors.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D009365 Neoplasm Regression, Spontaneous Disappearance of a neoplasm or neoplastic state without the intervention of therapy. Neoplasm Remission, Spontaneous,Remission, Spontaneous Neoplasm,Regression, Spontaneous Neoplasm,Spontaneous Neoplasm Regression,Spontaneous Neoplasm Remission
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D005134 Eye Neoplasms Tumors or cancer of the EYE. Cancer of Eye,Eye Cancer,Cancer of the Eye,Neoplasms, Eye,Cancer, Eye,Cancers, Eye,Eye Cancers,Eye Neoplasm,Neoplasm, Eye
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J Y Niederkorn, and P C Meunier
September 1986, Investigative ophthalmology & visual science,
J Y Niederkorn, and P C Meunier
June 1987, Journal of immunology (Baltimore, Md. : 1950),
J Y Niederkorn, and P C Meunier
May 1994, Current eye research,
J Y Niederkorn, and P C Meunier
August 1987, Klinische Monatsblatter fur Augenheilkunde,
J Y Niederkorn, and P C Meunier
September 2009, Progress in retinal and eye research,
J Y Niederkorn, and P C Meunier
December 2000, Journal of immunology (Baltimore, Md. : 1950),
J Y Niederkorn, and P C Meunier
January 1992, Immunopharmacology and immunotoxicology,
J Y Niederkorn, and P C Meunier
September 1986, Environmental health perspectives,
J Y Niederkorn, and P C Meunier
August 1994, Investigative ophthalmology & visual science,
Copied contents to your clipboard!